百晓学者学者目录

石晓静

副教授、教授、讲师,郑州大学

精选作品

期刊论文

2026

Overexpression of TFPI‐2 Suppresses Colorectal Cancer Progression by Inducing Ferroptosis via NF‐κB Signaling

Xiaojing Shi, Jing Zhang, Jian-Nan Lu, Zheng Xu

Journal of biochemical and molecular toxicology

2025

ROS-induced cytosolic release of mitochondrial PGAM5 promotes colorectal cancer progression by interacting with MST3

Shiyang Wang, Xi Wu, Wenxin Bi, Jiu-Zhi Xu, Liyuan Hou, Guilin Li, Yu-Wei Pan, Han-Fu Zhang, Mengzhen Li, Sujuan Du, Mingxin Zhang, Di Liu, Shuiling Jin, Xiaojing Shi, Yuhua Tian, Jian-Wei Shuai, M. Plikus, Mo-Shi Song, Zhao-Cai Zhou, Lu Yu, Cong Lv, Zheng-Quan Yu

Nature Communications

2025

Correction to "Discovery of Novel 5-Cyano-3-phenylindole-Based LSD1/HDAC Dual Inhibitors for Colorectal Cancer Treatment".

Hui-Juan Zhu, Hui-Min Zhou, Xiao-Xiao Zhou, Shi-Jie Li, Meng-Jie Zheng, Zhen Xu, Wen-Jing Dai, Yi-Bo Ban, Meng-Yao Zhang, Yizhe Zhang, Jia-Rui Lu, Yong-tao Xu, Sai-Qi Wang, Xiaojing Shi, Ying-Chao Duan

Journal of Medicinal Chemistry

2025

DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer

Xiao-Hong Zhao, M. Han, Qian-Qian Yan, Y. Yue, Kai-Hong Ye, Yuan-Yuan Zhang, Liu Teng, Liang Xu, Xiaojing Shi, La Ting, Yu-Chen Feng, Ran Xu, V. Narayana, D. D. de Souza, L. Quek, Jeff Holst, Tao Liu, Mark A. Baker, Rick F. Thorne, Xu-Dong Zhang, Lei Jin

Cell Death and Disease

2025

Single-cell analysis reveals that GFAP+ dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate/HMGB1 axis

Ziyang Zu, Chong Zhang, Jian-Xiang Shi, Kunlun Chen, Hongwei Tang, Kaizhao Hu, En-Chi Liu, C. Ji, Ruo Feng, Xiaojing Shi, Wen-Long Zhai

Cell Death and Disease

2025

Inhibition of Skp2 enhances anti-tumor immunity of macrophages by regulating CD47 in gastric cancer

Kaizhao Hu, Lidan Zhao, Peipei Miao, Wenhui Qiu, Lu Ai, Xi Chen, Xi Chen, Saiqi Wang, Xiaobing Chen, Xiaobing Chen, Xiaojing Shi

International Immunopharmacology

2025

Estrogen Promotes the Proliferation and Migration of Endometrial Cancer Through the GPER‐Mediated NOTCH Pathway

Meng Qi, Yuxi Jin, Lulu Si, Hanlin Fu, Xiaojing Shi, Yana Liu, Yifan Wang, Ruixia Guo

Journal of Biochemical and Molecular Toxicology

2025

IGFBP2 Promotes Proliferation and Glycolysis of Endometrial Cancer by Regulating PKM2 / HIF ‐1α Axis

Yuxi Jin, Meng Qi, Lulu Si, Xiaojing Shi, Mingbo Cai, Hanlin Fu, Yana Liu, Ruixia Guo

Cancer Science

2024

Discovery of Novel [1,2,4]Triazolo[1,5-a]pyrimidine Derivatives as Novel Potent S-Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer.

Kaizhao Hu, Yong Luo, Pei-Pei Miao, Lidan Zhao, Bing Zhao, Xiaojing Shi, Hong-Min Liu

Journal of Medicinal Chemistry

2024

Discovery of Novel 5-Cyano-3-phenylindole-Based LSD1/HDAC Dual Inhibitors for Colorectal Cancer Treatment.

Hui-Juan Zhu, Hui-Min Zhou, Xiao-Xiao Zhou, Shi-Jie Li, Meng-Jie Zheng, Zhen Xu, Wen-Jing Dai, Yi-Bo Ban, Meng-Yao Zhang, Yizhe Zhang, Jia-Rui Lu, Yong-tao Xu, Sai-Qi Wang, Xiaojing Shi, Ying-Chao Duan

Journal of Medicinal Chemistry

2024

HER2+ advanced gastric cancer: Current state and opportunities (Review)

Hui-Hui Hu, Saiqi Wang, Huichen Zhao, Zhe‐Sheng Chen, Xiaojing Shi, Xiaobing Chen

International Journal of Oncology

2023

Discovery of Novel 1,3-Diphenylpyrazine Derivatives as Potent S-Phase Kinase-Associated Protein 2 (Skp2) Inhibitors for the Treatment of Cancer

Kun Zhang, Kaizhao Hu, Qian Li, Min Li, Ke Gao, Kecheng Yang, Bing Zhao, Xiaojing Shi, Lirong Zhang, Hong‐Min Liu

Journal of Medicinal Chemistry

2023

Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors

Ying‐Chao Duan, Tong Yu, Linfeng Jin, Shaojie Zhang, Xiaojing Shi, Yizhe Zhang, Nanqian Zhou, Yongtao Xu, Wenfeng Lu, Huimin Zhou, Huijuan Zhu, Suping Bai, Kua Hu, Yuanyuan Guan

European Journal of Medicinal Chemistry

2023

Skp2 is a novel regulator of LSD1 expression and function in gastric cancer

Moges Dessale Asmamaw, Lirong Zhang, Hong‐Min Liu, Xiaojing Shi, Ying Liu

Genes & Diseases

2022

A comprehensive review of SHP2 and its role in cancer

Moges Dessale Asmamaw, Xiaojing Shi, Lirong Zhang, Hong‐Min Liu

Cellular Oncology

2021

Discovery of the antitumor activities of a potent DCN1 inhibitor compound 383 targeting LSD1 in gastric cancer

Zan Song, Ke Gao, Moges Dessale Asmamaw, Yue-Jiao Liu, Yi‐Chao Zheng, Xiaojing Shi, Hong‐Min Liu

European Journal of Pharmacology

2021

Publisher Correction: Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1

Kaizhao Hu, Xiaojing Li, Moges Dessale Asmamaw, Xiaojing Shi, Hong‐Min Liu

Scientific Reports

2021

Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1

Kaizhao Hu, Xiaojing Li, Moges Dessale Asmamaw, Xiaojing Shi, Hong‐Min Liu

Scientific Reports

2021

Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure

Jin‐Ling Huo, Lemin Jiao, Qi An, Xiuying Chen, Yuruo Qi, Bingfei Wei, Yi‐Chao Zheng, Xiaojing Shi, Erhe Gao, Hong‐Min Liu, Dong Chen, Cong Wang, Wen Zhao

Circulation Research

2021

Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy

Ying‐Chao Duan, Shaojie Zhang, Xiaojing Shi, Linfeng Jin, Tong Yu, Yu Song, Yuanyuan Guan

European Journal of Medicinal Chemistry

2021

Microbial profiling identifies potential key drivers in gastric cancer patients

Yonghong Li, Jia Wang, Mengge Wang, Yongshun Gao, Cheng-Yun Jin, Xiaojing Shi, Boyang Ji, Yongjun Wei, Hong‐Min Liu

Biotechnology & Biotechnological Equipment

2020

Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy

Xiaojing Shi, Shuai Wang, Xiaojing Li, Xiaohan Yuan, Lijuan Cao, Bin Yu, Hong‐Min Liu

European Journal of Medicinal Chemistry

2020

Skp2 in the ubiquitin‐proteasome system: A comprehensive review

Moges Dessale Asmamaw, Ying Liu, Yi‐Chao Zheng, Xiaojing Shi, Hong‐Min Liu

Medicinal Research Reviews

2020

RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma

Zhaoming Lu, Xiaojing Shi, Fanghua Gong, Shenglei Li, Yang Wang, Yandan Ren, Meng-Yin Zhang, Bin Yu, Yan Li, Wen He Zhao, Jianying Zhang, Guiqin Hou

Acta Pharmaceutica Sinica B

2019

Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors

Zhenzhen Liu, Taoqian Zhao, Zhonghua Li, Kai Sun, Yun-Dong Fu, Ting Cheng, Jimin Guo, Bin Yu, Xiaojing Shi, Hong‐Min Liu

Acta Pharmaceutica Sinica B

2019

The role of deubiquitinating enzymes in gastric cancer (Review)

Jiangang Sun, Xiaojing Shi, MAA Mamun, Yongshun Gao

Oncology Letters

2019

Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor

Pengxing He, Sheng-Hui Niu, Shuai Wang, Xiaojing Shi, Siqi Feng, Linna Du, Xuyang Zhang, Zhilu Ma, Bin Yu, Hong‐Min Liu

Acta Pharmaceutica Sinica B

2019

Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5-a]pyrimidine-Based Inhibitors Targeting the DCN1–UBC12 Protein–Protein Interaction

Shuai Wang, Shuai Wang, Lijie Zhao, Xiaojing Shi, Lina Ding, Linlin Yang, Zhi-Zheng Wang, Dandan Shen, Kai Tang, Xiaojing Li, MAA Mamun, Huiju Li, Bin Yu, Yi‐Chao Zheng, Shaomeng Wang, Shaomeng Wang, Hong‐Min Liu

Journal of Medicinal Chemistry

2019

A novel ent-kaurane diterpenoid analog, DN3, selectively kills human gastric cancer cells via acting directly on mitochondria

Yong‐Cheng Ma, Yingli Zhu, Nan Su, Yu Ke, Xiaxia Fan, Xiaojing Shi, Hong‐Min Liu, Ai-Feng Wang

European Journal of Pharmacology

2016

Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I

Xiaojing Shi, Lina Ding, Wenjuan Zhou, Yage Ji, Junwei Wang, Huimin Wang, Yong‐Cheng Ma, Guozhong Jiang, Kai Tang, Yu Ke, Wen Zhao, Hong‐Min Liu

Antioxidants and Redox Signaling

2016

Design, synthesis, and preliminary evaluation of the biological activity of dithiocarbamate-3-epi-jaspine B hybrids

En Zhang, Wei-Wei Jiao, Shang Wang, Jinmei Xu, Xiaojing Shi, Yanchao Wang, Yana Wang, Hong‐Min Liu

Medicinal Chemistry Research

2016

Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms

Xiaojing Shi, Bin Yu, Junwei Wang, Ping‐Ping Qi, Kai Tang, Xin Huang, Hong‐Min Liu

Scientific Reports

2016

Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach

Bin Yu, Ping‐Ping Qi, Xiaojing Shi, Ruilei Huang, Hao Guo, Yi‐Chao Zheng, De‐Quan Yu, Hong‐Min Liu

European Journal of Medicinal Chemistry

2015

六神丸抑制AOM/DSS诱导小鼠炎症相关性结直肠癌的作用

蔡杰,包益洁,于卉,石晓静,邹瑜,汤庆丰,殷佩浩

《武警后勤学院学报(医学版)》

2015

Efficient synthesis of novel antiproliferative steroidal spirooxindoles via the [3+2] cycloaddition reactions of azomethine ylides

Bin Yu, Xiao-Nan Sun, Xiaojing Shi, Ping‐Ping Qi, Yi‐Chao Zheng, De‐Quan Yu, Hong‐Min Liu

Steroids

2015

A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors

Yi‐Chao Zheng, Jinlian Ma, Zhiru Wang, Jinfeng Li, Bailing Jiang, Wenjuan Zhou, Xiaojing Shi, Xixin Wang, Wen Zhao, Hong‐Min Liu

Medicinal Research Reviews

2014

Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM–Chk1/2–Cdc25C pathway

Yong‐Cheng Ma, Nan Su, Xiaojing Shi, Wen He Zhao, Yu Ke, Xiaolin Zi, Ningmin Zhao, Yuhua Qin, Hongwei Zhao, Hong‐Min Liu

Toxicology and Applied Pharmacology

2014

Corrigendum to: “Design, synthesis and biological evaluation of novel steroidal spiro-oxindoles as potent antiproliferative agents” [J. Steroid Biochem. Mol. Biol. 141 (2014) 121–134]

Bin Yu, Xiaojing Shi, Ping‐Ping Qi, De-Quan Yu, Hong‐Min Liu

The Journal of Steroid Biochemistry and Molecular Biology

2014

Synthesis and preliminary biological evaluation of 1,2,3-triazole-Jaspine B hybrids as potential cytotoxic agents

Jinmei Xu, En Zhang, Xiaojing Shi, Yanchao Wang, Bin Yu, Wei-Wei Jiao, Ya-Zhuo Guo, Hong‐Min Liu

European Journal of Medicinal Chemistry

2013

新型对映-贝壳杉烷二萜化合物jaridonin体外抗肿瘤活性及其作用机制探讨

马永成,苏楠,石晓静,戴米洋,郑一超,刘宏民

《中国药学杂志》

2013

A novel [1,2,4] triazolo [1,5-a] pyrimidine-based phenyl-linked steroid dimer: Synthesis and its cytotoxic activity

Bin Yu, Xiaojing Shi, Yong‐Fei Zheng, Yuan Fang, En Zhang, De‐Quan Yu, Hong‐Min Liu

European Journal of Medicinal Chemistry

2013

Stereoselective synthesis of novel antiproliferative steroidal (E, E) dienamides through a cascade aldol/cyclization process

Bin Yu, Xiao-Nan Sun, Xiaojing Shi, Ping‐Ping Qi, Yuan Fang, En Zhang, De‐Quan Yu, Hong‐Min Liu

Steroids

2013

Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents

Ying‐Chao Duan, Yong‐Cheng Ma, En Zhang, Xiaojing Shi, Mengmeng Wang, Xian-Wei Ye, Hong‐Min Liu

European Journal of Medicinal Chemistry

会议论文

2013

OP46诱导人胃癌细胞MGC-803 G2/M期阻滞及其机制的研究

陈冬,石晓静,章旭耀,王西新,谷红丽,刘宏民

《2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议论文集》

2013

血清饥饿法用于人食管癌细胞周期归一化的方法学研究

马永成,石晓静,章旭耀,陈冬,王冉,刘宏民

《2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议论文集》

2013

抗肿瘤新药JD27通过线粒体途径诱导食管癌EC9706细胞凋亡

章旭耀,石晓静,马永成,陈冬,王冉,刘宏民

《2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议论文集》

2013

抗肿瘤新药JYD207诱导人食管癌细胞自噬及其机制的研究

章旭耀,石晓静,马永成,陈冬,王冉,刘宏民

《2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议论文集》

此主页由公开资料整理,尚未经学者本人认领。